PLASMA DERIVED MEDICINE MARKET ANALYSIS

Plasma Derived Medicine Market, By Product (Immunoglobulin, Coagulation factors, Albumin, and Others), By Application (Pelvic Inflammatory Disease (PID), Bleeding Disorders, Alpha-1 Antitrypsin Deficiency (AATD), Hereditary Angioedema (HAE), Chronic Inflammatory Demyelinating Polyneuropathy, Guillain-Barre Syndrome, Multifocal Motor Neuropathy, Liver Diseases, Primary Immune Thrombocytopenia, Infections, and Other Orphan Diseases), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Published In : Aug 2024
Code : CMI4929
Pages :156
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Concentration and Competitive Landscape

Plasma Derived Medicine Market Concentration By Players

Close-monitor your Competitor's Move, Request sample copy

Growing prevalence of chronic diseases

Rising prevalence of chronic diseases worldwide boosts uptake of plasma derived therapies. Conditions like primary immune thrombocytopenia (ITP), hemophilia and neurological disorders demand lifelong management, often with plasma derived medicines such as immunoglobulin therapies. Growing geriatric population prone to age related chronic illnesses also boost need for plasma products as replacement therapies. It is estimated that over 50% of plasma collected globally is utilized in manufacturing medicines for chronic diseases.

Lifestyle changes, expanding urbanization and increased life expectancy have led to rise in non-communicable chronic ailments. Developed nations have witnessed substantial disease burdens from chronic conditions which now account for the majority of national healthcare budgets. Emerging countries are also experiencing an epidemiological shift towards chronic illnesses due to rapid economic growth and changing dietary patterns. All of these factors have elevated the pool of patients requiring long term or repeated use of plasma therapies. Chronic diseases represent one of the biggest therapeutic areas for plasma derived medications.

Key Players Insights